Market revenue in 2023 | USD 1,930.5 million |
Market revenue in 2030 | USD 3,590.6 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Biocompatibility tests |
Fastest growing segment | Chemistry Test |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, NAMSA, Eurofins Scientific SE, Intertek Group PLC, Wuxi AppTec Co Ltd, TUV SUD, Element Materials Technology, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device testing services market will help companies and investors design strategic landscapes.
Biocompatibility tests was the largest segment with a revenue share of 49.88% in 2023. Horizon Databook has segmented the UK medical device testing services market based on biocompatibility tests, chemistry test, microbiology & sterility testing, package validation covering the revenue growth of each sub-segment from 2018 to 2030.
The UK medical device testing services market is projected to grow at 10.05% over the forecast period. Key drivers of the market include the presence of various multinational medical device companies, significant R&D spending, well-established healthcare infrastructure, healthcare research, high healthcare spending, and rapidly evolving demand for medical device testing for the development of new devices.
In addition, the UK government's initiatives to promote research drive market growth. For instance, in March 2022, the UK government allocated GBP 200.0 million to support NHS-led health research into diagnostics and treatment. Similar initiatives by the government in the future are expected to have a positive impact on the market.
Horizon Databook provides a detailed overview of country-level data and insights on the UK medical device testing services market , including forecasts for subscribers. This country databook contains high-level insights into UK medical device testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account